Pay in 4 interest-free payments of $5.57 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
This meta-analysis showed that, over 398 patients with schizophrenia treated with antipsychotic followed up between 12 and 24 weeks, the GLP-1RAs liraglutide and exenatide were superior to placebo for body weight, waist circumference, BMI and blood pressure 134
The limited treatment landscape has created significant interest in repurposing existing drugs, particularly glucagon-like peptide-1 (GLP-1) receptor agonists, which address multiple metabolic pathways implicated in fatty liver disease
In summary, anyone can receive this treatment to live a healthier life except for the special cases given above
10.1016/S0887-8994(97)00026-X Warter JM, Imler M, Marescaux C, Chabrier G, Rumbach L, Micheletti G, Krieger J: Sodium valproate-induced hyperammonemia in the rat: role of the kidney
